The Efficacy Comparison Between Mirabegron and Antimuscarinics in Treating Overactive Bladder: a Systematic Review and Meta-Analysis

• In: Poster Presentation
• At: Stockholm (Sweden) (2017)
• Type: Poster
• Poster code: P-E-007-Monday
• By: CHEN, Hsiao Ling (Kaohsiung Municipal Ta-Tung Hospital, Kaohsiung,Taiwan, Pharmacy, Kaohsiung City, China Taiwan)
• Co-author(s): Hsiao Ling Chen: Department of Pharmacy, Kaohsiung Municipal Ta-Tung Hospital, Kaohsiung, Taiwan, Kaohsiung City, Taiwan, Province of China
  Tun-Cheh Chen: Division of Infectious Diseases, Kaohsiung Municipal Ta-Tung Hospital, Kaohsiung, Taiwan, Kaohsiung City, Taiwan, Province of China
  Hsiang Ying Lee: Department of Urology, Kaohsiung Municipal Ta-Tung Hospital, Kaohsiung, Taiwan, Kaohsiung City, Taiwan, Province of China
  Wei-Hsuan Huang: Department of Pharmacy, Kaohsiung Municipal Ta-Tung Hospital, Kaohsiung, Taiwan, Kaohsiung City, Taiwan, Province of China
  Hung-Fang Pan: Department of Pharmacy, Kaohsiung Municipal Ta-Tung Hospital, Kaohsiung, Taiwan, Kaohsiung City, Taiwan, Province of China
  Chiou-Mei Wu: Department of Pharmacy, Kaohsiung Municipal Ta-Tung Hospital, Kaohsiung, Taiwan, Kaohsiung City, Taiwan, Province of China
  Ya-Ling Wang: Department of Pharmacy, Kaohsiung Medical University Hospital, Kaohsiung City, Taiwan, Province of China
  Hsiu-Mei Chang: Department of Pharmacy, Kaohsiung Municipal Ta-Tung Hospital, Kaohsiung, Taiwan, Kaohsiung City, Taiwan, Province of China
  Yong-Chieh Chang: Department of Pharmacy, Kaohsiung Municipal Ta-Tung Hospital, Kaohsiung, Taiwan, Kaohsiung City, Taiwan, Province of China
  
• Abstract:

  Backgrounds

  Antimuscarinic drugs have been the first line choice of overactive bladder (OAB) treatment; however, side effects were clearly a major reason for noncompliance. Mirabegron, a β3-adrenoceptor agonist, was investigated to be effective and safe for OAB.

  Aims

  To perform a meta-analysis on the efficacy comparison between antimuscarinics and
  ..

The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login